Fattal Holdings (FTAL) Fair Value & Analysis
Consumer Cyclical · Il · Market cap 11.7B ILA
Fair value as of: Jul 15, 2026
From 16 valuation models · updated 26 days ago
Share price −9.7% over the past month.
Below-average quality, and screening another 86% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (125.85 ILA). The favourable scenario is already priced in.
- Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (64.51 ILA to 125.85 ILA) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.
How to read this chart
60‑month range 248.95 ILA – 882.89 ILA · fair‑value band 64.51 ILA – 125.85 ILA · the 693.80 ILA price screens above the 96.81 ILA fair value. Dashed = 300-day average. As of Jul 15, 2026.
Analysis
Fattal Holdings (FTAL) currently trades at 693.80 ILA, while our model-based Fair Value estimate is 96.81 ILA, implying the stock looks roughly 86.0% overvalued today. The Quality Score stands at 28/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Fattal Holdings generated revenue of 7.6B ILA at a net margin of -0.1%. Revenue declined 4.7% year over year. Net debt stands at 22.0B ILA. Fundamentals as of Jul 15, 2026
Our scenario range runs from 64.51 ILA (bear case) to 125.85 ILA (bull case); at 693.80 ILA, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Consumer Cyclical peers we cover trades at -62% fair-value upside, at -86%, FTAL screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Asset-Based (186.45 ILA) versus Multiples (71.07 ILA). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 29 · Market factors (momentum, volatility) 53
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Fattal Holdings (1998) Ltd owns and operates hotels in Israel and internationally. The company also manages and leases hotels under the Leonardo brand name. Fattal Holdings (1998) Ltd was incorporated in 1998 and is based in Tel Aviv-Yafo, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Fattal Holdings reported revenue of 7.6B ILA in FY2025 versus 3.0B ILA in FY2021, a compound +25.9%/yr. Reported net income was 53.3M ILA in FY2025.
FTAL screens 86% overvalued. Compare with Marriott International, Inc →
Peer Group
Lodging · 170 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Lodging median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Lodging stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Marriott International, Inc MAR | $369.05 | $135.64 | -63% |
| Hilton Worldwide Holdings HLT | $328.48 | $123.67 | -62% |
| InterContinental Hotels Group IHG | $159.87 | $85.18 | -47% |
| Hyatt Hotels Corporation H | $191.00 | $47.69 | -75% |
| H World Group HTHT | $42.67 | $47.55 | +11% |
| Accor SA AC | €47.25 | €39.26 | -17% |
| The Indian Hotels Company INDHOTEL | ₹743.20 | ₹260.68 | -65% |
| Wyndham Hotels & Resorts, Inc WH | $78.54 | $24.02 | -69% |
| Hanjin Kal, 180640 | 113,500 KRW | 36,890 KRW | -67% |
| Jabal Omar Development Company 4250 | 16.00 SAR | 11.64 SAR | -27% |
Compare Fattal Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Fattal Holdings (FTAL) overvalued or undervalued?
What is the fair value of FTAL?
What is the quality score of FTAL?
What is the revenue of Fattal Holdings (FTAL)?
What is the net profit margin of FTAL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Fattal Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.